Mead Johnson Nutrition Company Stock Buy Recommendation Reiterated (MJN)
- ACTIVE STOCK TRADERS: Get trading ideas for stocks under $10 for less than $6/week. Start with a 14-Day Free Trial.
- The revenue growth came in higher than the industry average of 7.0%. Since the same quarter one year prior, revenues slightly increased by 8.6%. Growth in the company's revenue appears to have helped boost the earnings per share.
- MEAD JOHNSON NUTRITION CO has improved earnings per share by 26.6% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, MEAD JOHNSON NUTRITION CO increased its bottom line by earning $2.47 versus $2.20 in the prior year. This year, the market expects an improvement in earnings ($3.10 versus $2.47).
- The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Food Products industry. The net income increased by 25.5% when compared to the same quarter one year prior, rising from $132.10 million to $165.80 million.
- Net operating cash flow has significantly increased by 167.60% to $247.80 million when compared to the same quarter last year. In addition, MEAD JOHNSON NUTRITION CO has also vastly surpassed the industry average cash flow growth rate of -2.69%.
- The gross profit margin for MEAD JOHNSON NUTRITION CO is rather high; currently it is at 65.10%. Regardless of MJN's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, MJN's net profit margin of 16.40% compares favorably to the industry average.
--Written by a member of TheStreet Ratings Staff. FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free Download Now
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts